Photobiomodulation is the mechanism by which non-ionizing optical radiation in the visible and near-infrared spectral range is absorbed by endogenous chromophores to elicit photo-physical and photo-chemical events at various biological scales. Photobiomodulation Therapy (PBMT) is a form of light therapy based on the principles of photobiomodulation. It involves the use of light sources including lasers, LEDs, and broadband light, in the visible and infrared spectrum to cause physiological changes and therapeutic benefits. PBMT has the potential to revolutionize modern healthcare and is being used by veterinarians, dentists and physical therapists for a number of applications including tissue regeneration, pain relief and regulation of inflammation. New areas of research include as age-related macular degeneration, spinal cord injury, and traumas and pathologies of the brain. The focus of the OSA Photobiomodulation Technical Group will be to develop guidelines to help ensure safety, efficacy and scientific accuracy in photobiomodulation research and technology development.
||U.S. Food and Drug Administration||Vice Chair
||American Institute of Medical Laser Appl||Events Officer
||Academy of Laser Dentistry||Events Officer
||THOR Photobiomodulation Ltd||Social Media Officer
|| ||Social Media Officer
||University at Buffalo||Webinar Officer
||Harvard Medical School||Webinar Officer
29 October 2018
New Century Grand Hotel
10 May 2019
The San Jose McEnery Convention Center
Become a members of our newest technical group today! OSA Members can join the Photobiomodulation Technical Group by updating their profile in My Account.
Join the Photobiomodulation Techical Group >>
In 2015, leaders of this technical group hosted an OSA Incubator Meeting
focused on the discussion and dissemination of scientifically sound research in the field of Photobiomodulation. You can read more about this meeting in the following blog posts:
, an OSA Fellow, played an instrumental role in establishing the credibility of Photobiomodulation in the academic community and funding agencies in the United States. His sad passing in 2016 is a great loss to the Photobiomodulation community.
Join our Online Community